ViiV/J&J’s long-acting HIV regimen finally approved in USThe FDA has approved Cabenuva, a long-acting HIV treatment from ViiV and Johnson & Johnson that keeps the Share XViiV/J&J’s long-acting HIV regimen finally approved in UShttps://pharmaphorum.com/news/fda-finally-approves-viiv-jjs-long-acting-hiv-regimen/
NICE rejects BMS’ Zeposia MS pill in provisional guidanceNICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing Share XNICE rejects BMS’ Zeposia MS pill in provisional guidancehttps://pharmaphorum.com/market-access-2/nice-rejects-bms-zeposia-ms-pill-in-provisional-guidance/
Nearly half of UK young people buy meds after consulting “Dr Google”It’s evident that relying on Google for a health diagnosis isn’t a good idea, but it seems a Share XNearly half of UK young people buy meds after consulting “Dr Google”https://pharmaphorum.com/news/nearly-half-of-uk-young-people-buy-meds-after-consulting-dr-google/
3 practical steps for improving patient supportResearch Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to Share X3 practical steps for improving patient supporthttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/practical-steps-for-improving-patient-support/
Health literacy needs support, now more than everThe COVID-19 pandemic has brought healthcare guidelines and scientific advances front-of-mind on a global scale, in the process Share XHealth literacy needs support, now more than everhttps://pharmaphorum.com/views-analysis-patients/health-literacy-needs-support-now-more-than-ever/
Digital passports – could they help life return to normal?While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination Share XDigital passports – could they help life return to normal?https://pharmaphorum.com/views-analysis-digital/digital-passports-could-they-help-life-return-to-normal/
3 practical steps for improving patient supportResearch Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to Share X3 practical steps for improving patient supporthttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/practical-steps-for-improving-patient-support/
A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
Enabling new models of care: pursuing pharma’s partnership potentialThere is a huge, ongoing shift in how health and wellness is approached in the UK, and the Share XEnabling new models of care: pursuing pharma’s partnership potentialhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/enabling-new-models-of-care-pursuing-pharmas-partnership-potential/
Coordinating and delivering research in the pandemic: The UK approach Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coronavirus-research-nihr/
Increasing patient engagement with UK clinical trials Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Introducing the new NIHR National Patient Recruitment Centres Share XIntroducing the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/webinars/nihr-national-patient-recruitment-centres/
Plugging modular content into pharma’s omnichannel strategies86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a Share XPlugging modular content into pharma’s omnichannel strategieshttps://pharmaphorum.com/whitepapers/plugging-modular-content-into-pharmas-omnichannel-strategies/
Pharma digital transformation: customer data expected to play a pivotal roleA new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies Share XPharma digital transformation: customer data expected to play a pivotal rolehttps://pharmaphorum.com/whitepapers/pharma-digital-transformation-customer-data-expected-to-play-a-pivotal-role/
Digitally engaging doctors around the worldPharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of Share XDigitally engaging doctors around the worldhttps://pharmaphorum.com/whitepapers/digitally-engaging-doctors-around-the-world/
The Alderley Park Discovery Podcast: Life science skills, staffing and support Share XThe Alderley Park Discovery Podcast: Life science skills, staffing and supporthttps://pharmaphorum.com/podcast/alderley-park-life-science-skills-staffing/
J&J and medical device innovation: the pharmaphorum podcast Share XJ&J and medical device innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/johnson-medical-device-innovation/
Tay-Sachs and rare disease registries – the Health Heroes podcast Share XTay-Sachs and rare disease registries – the Health Heroes podcasthttps://pharmaphorum.com/podcast/rare-disease-registries-kantar-health/
First Psychiatry Consortium funded project announced for schizophrenia Share XFirst Psychiatry Consortium funded project announced for schizophreniahttps://pharmaphorum.com/partner-content/first-psychiatry-consortium-funded-project-announced-for-schizophrenia/
Testing Lab Data Reveals Spread of New Covid Variant Across the Country Share XTesting Lab Data Reveals Spread of New Covid Variant Across the Countryhttps://pharmaphorum.com/partner-content/testing-lab-data-reveals-spread-of-new-covid-variant-across-the-country/
Using Define-XML for Dataset Design Share XUsing Define-XML for Dataset Designhttps://pharmaphorum.com/partner-content/using-define-xml-for-dataset-design/
UK Innovators Target Nanoparticles at Inoperable Cancers Share XUK Innovators Target Nanoparticles at Inoperable Cancershttps://pharmaphorum.com/partner-content/uk-innovators-target-nanoparticles-at-inoperable-cancers/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
Prescient Announces Recent Appointments to its Senior Team Share XPrescient Announces Recent Appointments to its Senior Teamhttps://pharmaphorum.com/partner-content/prescient-announces-recent-appointments-to-its-senior-team/
